SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,249.39 -460.30
( -0.62%)

Global Indices

Nasdaq

52,880.09 363.21
(0.69%)

Dow Jones

7,780.08 46.51
(0.60%)

Hang Seng

63,134.14 -1,487.10
(-2.30%)

Nikkei 225

10,751.68 18.68
(0.17%)

Forex

USD-INR

94.82 -0.08
(-0.09%)

EUR-INR

106.45 0.01
(0.01%)

GBP-INR

126.63 0.25
(0.20%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

corom&el international ltd

Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter

Aug 04,2026

Net profit of Alembic Pharmaceuticals rose 12.11% to Rs 173.07 crore in the quarter ended June 2026 as against Rs 154.38 crore during the previous quarter ended June 2025. Sales rose 25.66% to Rs 2149.77 crore in the quarter ended June 2026 as against Rs 1710.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2149.77	1710.72	26
OPM %	15.44	16.42	-
PBDT	319.57	263.88	21
PBT	221.86	190.11	17
NP	173.07	154.38	12

73,249.39 -460.30 ( -0.62%)

52,880.09 363.21 (0.69%)

7,780.08 46.51 (0.60%)

63,134.14 -1,487.10 (-2.30%)

10,751.68 18.68 (0.17%)

94.82 -0.08 (-0.09%)

106.45 0.01 (0.01%)

126.63 0.25 (0.20%)

0.60 0.00 (-0.04%)